Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice

Human Molecular Genetics

Volumn 10, Issue 22, 2001, Pages 2525-2537

  Lesuisse, Christian ^a   Xu, Guilian ^a,b   Anderson, Jeffery ^c   Wong, Molly ^b   Jankowsky, Joanna ^a   Holtz, Greg ^c   Gonzalez, Victoria ^a   Wong, Philip C Y ^a   Price, Donald L ^a   Tang, Fai ^b   Wagner, Steve ^c,d   Borchelt, David R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c MERCK RESEARCH LABORATORIES   (United States)

^d Neurogenetics Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E4; MUTANT PROTEIN; PRESENILIN 1; PRION PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; GENE FUNCTION; HUMAN; LIFESPAN; MACROGLIA; MECHANICS; MOUSE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TRANSGENIC MOUSE;

ANIMALIA; MUS MUSCULUS;

EID: 0035888598     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/10.22.2525     Document Type: Article

References (96)

1. Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein
2. Amyloid β-peptide is produced by cultured cells during normal metabolism
3. Production of the Alzheimer amyloid β protein by normal proteolytic processing
4. Mutation of the β-amyloid precursor protein in familial Alzheimer's disease increases β-protein production
5. Release of excess amyloid β protein from a mutant amyloid β protein precursor
6. Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid β-protein precursor
7. 717) mutants
8. Secreted amyloid β-protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease
9. Familial Alzheimer's disease-linked presenilin 1 variants elevate Aβ1-42/1-40 ratio in vitro and in vivo
10. Increased amyloid-β42(43) in brains of mice expressing mutant presenilin 1
11. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid β-protein in both transfected cells and transgenic mice
12. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue
13. Accelerated amyloid deposition in the brains of transgenic mice co-expressing mutant presenilin 1 and amyloid precursor proteins
14. Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes
15. Visualization of Aβ42(43)-positive and Aβ40-positive senile plaques with end-specific Aβ-monoclonal antibodies: Evidence that an initially deposited Aβ species is Aβ1-42(43)
16. Amyloid β protein (Aβ) in Alzheimer's disease brain
17. Amyloid β protein (Aβ) deposition: Aβ42(43) precedes Aβ40 in Down syndrome
18. Sequence of deposition of heterogeneous amyloid β-peptides and APO E in Down syndrome: Implications for initial events in amyloid plaque formation
19. Structural alterations in the peptide backbone of β-amyloid core protein may account for its deposition and stability in Alzheimer's disease
20. The Alzheimer diseases
21. Apolipoprotein E in neurology
22. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer's disease
23. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease
24. Apolipoprotein E polymorphism influences not only cerebral senile plaque load but also Alzheimer-type neurofibrillary tangle formation
25. A β-peptide length and apolipoprotein E genotype in Alzheimer's disease
26. Clinical and pathological correlates of apolipoprotein E ε4 in Alzheimer disease
27. Apolipoprotein E polymorphism is associated with both senile plaque load and Alzheimer-type neurofibrillary tangle formation
28. The apolipoprotein E ε4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant
29. 40 in Alzheimer's disease is associated with a gene dosage effect of the apolipoprotein E E4 allele
30. Lack of apolipoprotein E dramatically reduces amyloid B-peptide deposition
31. V717F transgenic mouse model of Alzheimer's disease
32. Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease
33. A thrombin cleavage fragment of apolipoprotein E exhibits isoform-specific neurotoxicity
34. A vector for expressing foreign genes in the brains and hearts of transgenic mice
35. Intranuclear inclusions and neuritic pathology in transgenic mice expressing a mutant N-terminal fragment of huntingtin
36. Nuclear accumulation of truncated atrophin-1 fragments in a transgenic mouse model of DRPLA
37. Nearly ubiquitous tissue distribution of the scrapie agent precursor protein
38. Scrapie-associated prion protein accumulates in astrocytes during scrapie infection
39. Expression in mouse embryos and in adult mouse brain of three members of the amyloid precursor protein family, of the α-2-macroglobulin receptor/low density lipoprotein receptor-related protein and of its lipoprotein lipase, α-2-macroglobulin and the 40,000 molecular weight receptor-associated protein
40. Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: Astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins
41. Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: Implications for Huntington's disease therapy
42. Huntingtin-encoded polyglutamine expansions form amyloid-like protein aggregates in vitro and in vivo
43. Self-assembly of polyglutamine-containing huntingtin fragments into amyloid-like fibrils: Implications for Huntington's disease pathology
44. Q111 knock-in mice
45. Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice
46. Mutant mice and neuroscience: Recommendations concerning genetic background
47. Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis
48. Alzheimer's disease and senile dementia: Loss of neurons in the basal forebrain
49. Alzheimer's disease and related dementias: Selective involvement of specific neuronal systems
50. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
51. Apolipoprotein E: A pathological chaperone protein in patients with cerebral and systemic amyloid
52. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid β-peptide (Aβ) in cases with or without Alzheimer's disease
53. Apolipoprotein E ε4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy
54. Apolipoprotein E genotype and amyloid load in Alzheimer disease and control brains
55. Differences in the Aβ40/Aβ42 ratio associated with cerebrospinal fluid lipoproteins as a function of apolipoprotein E genotype
56. 1-antichymotrypsin and apolipoprotein E promote the assembly of the Alzheimer β-protein into filaments
57. Specific modulation of the fusogenic properties of the Alzheimer β-amyloid peptide by apolipoprotein E isoforms
58. Seeding of Aβ fibril formation is inhibited by all three isotypes of apolipoprotein E
59. Expression of human apolipoprotein E reduces amyloid-β deposition in a mouse model of Alzheimer's disease
60. The neurobiology of apolipoproteins and their receptors in the CNS and Alzheimer's disease
61. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice
62. Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model
63. Simvastatin strongly reduces levels of Alzheimer's disease β-amyloid peptides Aβ42 and Aβ40 in vitro and in vivo
64. The role of cholesterol in the biosynthesis of β-amyloid
65. Platelet secretion of β-amyloid is increased in hypercholesterolaemia
66. Low cholesterol stimulates the nonamyloidogenic pathway by its effect on the α-secretase ADAM 10
67. Amyloid precursor protein in unique cholesterol-rich microdomains different from caveolae-like domains
68. Amyloid precursor protein, although partially detergent-insoluble in mouse cerebral cortex, behaves as an atypical lipid raft protein
69. Cholesterol-dependent generation of a seeding amyloid β-protein in cell culture
70. Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line
71. The mammalian low-density lipoprotein receptor family
72. LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted β-amyloid precursor protein and mediates its degradation
73. Cell surface APP751 forms complexes with protease nexin 2 ligands and is internalized via the low density lipoprotein receptor-related protein (LRP)
74. The low-density lipoprotein receptor-related protein, a multifunctional apolipoprotein E receptor, modulates hippocampal neurite development
75. Modulation of β-amyloid precursor protein processing by the low density lipoprotein receptor-related protein (LRP)
76. -/- mice: Isoform-specific effects on neurodegeneration
77. Apolipoprotein E ε4 allele and hippocampal volume in twins with normal cognition
78. Alzheimer Aβ neurotoxicity: Promotion by antichymotrypsin, ApoE4; inhibition by Aβ-related peptides
79. Hypothesis: Microtubule instability and paired helical filament formation in the Alzheimer disease brain are related to apolipoprotein E genotype
80. Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system
81. Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes
82. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study
83. Apolipoprotein E is localized to the cytoplasm of human cortical neurons: A light and electron microscopic study
84. Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain
85. Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: Implications for Alzheimer's disease
86. s) is preferentially associated with neuron-enriched cultures from APOE transgenic mice
87. Specific regional transcription of apolipoprotein E in human brain neurons
88. Apolipoprotein E, a gene with complex biological interactions in the aging brain
89. Hyperaccumulation of FAD-linked presenilin 1 variants in vivo
90. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
91. Improved electrophorectic separation and immunoblotting of β-amyloid (Aβ) peptides 1-40, 1-42, and 1-43
92. Expression of presenilin 1 and 2 (PS1 and PS2) in human and murine tissues
93. Endoproteolysis of presenilin 1 and accumulation of processed derivatives in vivo
94. A rapid radiochemical method for the determination of choline acetyltransferase
95. A new and rapid colorimetric determination of acetylcholinesterase activity